247570-24-7 Usage
Description
1-N-Boc-cis-1,4-cyclohexyldiamine is a chemical compound that features a cyclohexane ring with two amine groups attached at the 1 and 4 positions, and a Boc (tert-butyloxycarbonyl) protecting group on the nitrogen atom. This structure provides it with unique properties and reactivity, making it suitable for various applications across different industries.
Uses
Used in Agrochemical Industry:
1-N-Boc-cis-1,4-cyclohexyldiamine is used as an intermediate in the synthesis of agrochemicals for its ability to form stable and effective compounds that can be used in pest control and crop protection.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-N-Boc-cis-1,4-cyclohexyldiamine is used as a building block in the development of new drugs. Its unique structure allows for the creation of molecules with specific biological activities, potentially leading to the discovery of novel therapeutic agents.
Used in Dye Industry:
1-N-Boc-cis-1,4-cyclohexyldiamine is utilized in the dyestuff field as a precursor for the synthesis of various dyes and pigments. Its chemical properties enable the production of colorants with desirable characteristics, such as stability and color intensity, for use in textiles, plastics, and other applications.
Check Digit Verification of cas no
The CAS Registry Mumber 247570-24-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,7,5,7 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 247570-24:
(8*2)+(7*4)+(6*7)+(5*5)+(4*7)+(3*0)+(2*2)+(1*4)=147
147 % 10 = 7
So 247570-24-7 is a valid CAS Registry Number.
247570-24-7Relevant articles and documents
INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE
-
, (2018/06/30)
The present disclosure is directed to compounds of Formula (I) and methods of their use and preparation, as well as compositions comprising compounds of Formula (I).
SELECTIVE KINASE INHIBITORS
-
, (2013/06/06)
Provided are pyrimidine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibition Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.
Crystalline forms of cis-5-fluoro-N-?4-(2-hydroxy-4-methylbenzamido)cyclohexyl|-2-(tetrahydrothiopyran-4-yloxy)nicotinamide
-
Page/Page column 14; 15, (2008/06/13)
The present invention relates to new crystalline forms of syn-5-Fluoro-N-[4-(2-hydroxy-4-methyl-benzoylamino)-cyclohexyl]-2-(tetrahydro-thiopyran-4-yloxy)-nicotinamide and to processes for the preparation of, compositions containing and the uses of such crystalline forms.